Open-source de novo protein binder design suite from ByteDance combining diffusion and hallucination generators with confidence-based filtering, reaching nanomolar experimental hit rates.
PXDesign is an open-source software suite for the de novo design of protein binders, released by the Protenix Team within ByteDance's Seed organization and posted to bioRxiv in December 2025. The system addresses one of the central challenges in protein engineering: generating novel mini-protein binders that bind a chosen target with high affinity, starting only from the target structure and with no natural binder to use as a template. Rather than relying on a single generative trick, PXDesign packages a full, modular pipeline — backbone generation, sequence design, and confidence-based filtering — into a reproducible framework.
PXDesign is closely related to, but distinct from, ByteDance's Protenix model. Protenix is an open-source reproduction of AlphaFold 3 used for biomolecular structure prediction. PXDesign is a design suite that consumes structure-prediction models — including Protenix and AlphaFold2 in interface-guided mode (AF2-IG) — as scoring and filtering engines to rank candidate designs. In other words, Protenix is one of the components PXDesign relies on, not a substitute for it.
The work is notable for pairing strong in-silico benchmarks with extensive wet-lab validation across multiple diverse targets, and for shipping under a permissive Apache 2.0 license alongside a free public web server, lowering the barrier for academic and industrial groups to run binder-design campaigns.
PXDesign-d is a diffusion model that generates protein-binder backbones conditioned on the target structure; PXDesign-h instead hallucinates binders by optimizing inputs against a structure predictor's confidence signal. Generated backbones are passed to ProteinMPNN for sequence design, and the resulting designs are filtered and ranked using confidence estimates from Protenix and AF2-IG. The authors report that PXDesign-d achieves higher success rates and broader fold diversity than RFdiffusion across ten targets in silico, and is more throughput-efficient than hallucination for large-scale campaigns. Experimentally, PXDesign produced nanomolar binders with hit rates of 17–82% on six of seven targets drawn from a diverse panel including IL-7RA, PD-L1, VEGF-A, the SARS-CoV-2 receptor-binding domain, TrkA, and EGFR. Model checkpoints (the diffusion generator plus Protenix base and mini variants) download automatically on first run, and external tool weights such as AF2 and ProteinMPNN are fetched via a provided script.
PXDesign targets researchers in therapeutic antibody alternatives, biologics discovery, and synthetic biology who need to generate high-affinity binders against a structurally defined target without an existing template. Typical use cases include designing mini-protein binders to receptors and viral antigens for diagnostics, as research reagents, or as starting points for therapeutic development. Because the suite is modular and open-source, computational groups can swap in alternative generators or filters, while experimentalists with no machine-learning infrastructure can use the free web server to produce ranked candidate sequences for direct wet-lab testing.
By coupling competitive in-silico performance with experimentally validated nanomolar hit rates and an unrestricted Apache 2.0 license, PXDesign contributes a practical, reproducible alternative to closed or restrictively licensed binder-design pipelines. Its public web server, launched in September 2025, has supported numerous researchers in identifying binders for wet-lab validation, and the companion PXDesignBench framework offers a shared yardstick for comparing future methods. Key limitations follow from its dependence on structure-prediction confidence as a proxy for binding: hit rates vary substantially by target, success is not guaranteed for the most difficult interfaces, and as a preprint-stage release some benchmark claims await peer review and broader independent reproduction.
Team, P., et al. (2025) PXDesign: Fast, Modular, and Accurate De Novo Design of Protein Binders. bioRxiv.
DOI: 10.1101/2025.08.15.670450Papers that recently cited this model.
Hanqun Cao, Z. Quinn, Aastha Pal, et al.
Jun 2026
Mikel Landajuela
bioRxiv · May 2026
Jeffrey K. Weber, Gyanu Parajuli, Stephen Wang, et al.
bioRxiv · May 2026
The most-cited papers that cite this model.
Yuxuan Zhang, Chengyue Gong, Hanyu Zhang, et al.
bioRxiv · Feb 2026
Odin Zhang, Xujun Zhang, Haitao Lin, et al.
Oct 2025
Minchao Fang, Chentong Wang, Jungang Shi, et al.
bioRxiv · Jan 2026
Wei Yang, Shunzhi Wang, G. Lee, et al.
Nature · Apr 2026
Share of papers citing this model.